This investment opportunity offers a unique chance for individuals and institutions to actively participate in the growth and transformation of the healthc...
The first patient was randomized in China in the NATiV3 Phase III clinical trial, triggering a milestone payment of $3 million from CTTQ to Inventiva.&nb...
ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment, announced the close of a $2...
Perpetual Medicines announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for pe...
The investment will significantly increase the capacity of the manufacturing site, adding aseptic production and finished production processes and an exten...
-Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-cen...
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...
Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to con...
Evozyne announced the closing of an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform ...
-Brain diagnostics innovator BrainScope announced a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s ...
Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...
"We are thrilled to receive this investment from KITVEN and Conscience Multi Family Office," said Dr. Chandrashekaran. "This funding will empower us to f...
LUNAR-FLU collaboration with CSL Seqirus achieves additional $17.5 million development milestone Arcturus Therapeutics Holdings Inc. (the “C...
© 2024 Biopharma Boardroom. All Rights Reserved.
